Smanik E J, Young H K, Muldoon T G, Mahesh V B
Endocrinology. 1983 Jul;113(1):15-22. doi: 10.1210/endo-113-1-15.
An acute injection of estradiol is known to cause a rapid redistribution of estrogen receptors in responsive cells, measurable as depletion of the cytosol receptor content with accompanying accumulation in the nucleus. We have examined the effects of progesterone on this process in the anterior pituitary and hypothalamus using an animal model in which sensitivity to steroidal feedback control of gonadotropin secretion has been defined. Ovariectomized immature rats were administered low dose estrogen replacement for 4 days. On the morning of the fifth day, groups of animals were injected according to one of the following protocols: 1) vehicle alone; 2) 5 or 10 micrograms estradiol; and 3) 0.8 or 3.2 mg progesterone, followed 1 h later by vehicle or 5 or 10 micrograms estradiol. All animals were killed 1 h after estradiol (or vehicle) injection, and levels of cytosol and nuclear estrogen receptors were measured. The only change occasioned by progesterone treatment was a decrease in anterior pituitary nuclear estrogen receptor levels. At the 5-microgram dose of estradiol, 0.8 and 3.2 mg progesterone were equally effective in diminishing nuclear estrogen receptor binding. When 10 micrograms estradiol were used to cause receptor redistribution, only the higher 3.2-mg dose of progesterone significantly depressed nuclear receptor binding. If ovariectomized animals were maintained in the absence of estrogen replacement, progesterone at either the 0.8- or 3.2-mg dosage was completely ineffective in altering the patterns of estradiol-induced cytosol or nuclear estrogen receptor levels. The results demonstrate a tissue-specific inhibitory action of progesterone on estrogen-induced enhancement of nuclear estrogen receptor binding. This inhibition can be partially overcome by increasing the level of estrogen used to effect receptor redistribution. The requirement for maintenance of a background level of estrogen suggests that the inhibitory action of progesterone is mediated through progesterone receptor interactions.
已知急性注射雌二醇会导致雌激素受体在反应性细胞中快速重新分布,这可通过胞质溶胶受体含量的减少以及细胞核中相应积累来衡量。我们使用一种已定义对促性腺激素分泌的甾体反馈控制敏感性的动物模型,研究了孕酮对垂体前叶和下丘脑这一过程的影响。对去卵巢的幼鼠给予低剂量雌激素替代物,持续4天。在第5天早晨,将动物分组并按照以下方案之一进行注射:1)仅注射溶剂;2)注射5或10微克雌二醇;3)注射0.8或3.2毫克孕酮,1小时后再注射溶剂或5或10微克雌二醇。在注射雌二醇(或溶剂)1小时后处死所有动物,并测量胞质溶胶和细胞核雌激素受体的水平。孕酮处理仅引起垂体前叶细胞核雌激素受体水平降低。在使用5微克剂量雌二醇时,0.8毫克和3.2毫克孕酮在减少细胞核雌激素受体结合方面同样有效。当使用10微克雌二醇引起受体重新分布时,只有较高剂量的3.2毫克孕酮能显著降低细胞核受体结合。如果在没有雌激素替代物的情况下饲养去卵巢动物,0.8毫克或3.2毫克剂量的孕酮在改变雌二醇诱导的胞质溶胶或细胞核雌激素受体水平模式方面完全无效。结果表明,孕酮对雌激素诱导的细胞核雌激素受体结合增强具有组织特异性抑制作用。通过增加用于实现受体重新分布的雌激素水平,这种抑制作用可部分被克服。维持雌激素背景水平的必要性表明,孕酮的抑制作用是通过孕酮受体相互作用介导的。